Intranasal insulin linked to reduced food intake

June 7, 2012
Intranasal insulin linked to reduced food intake
Intranasally administered insulin is associated with higher brain energy levels and reduced calorie intake, according to a study published online May 14 in Diabetes.

(HealthDay) -- Intranasally administered insulin is associated with higher brain energy levels and reduced calorie intake, according to a study published online May 14 in Diabetes.

To examine whether intranasal insulin reduced food consumption by increasing neuroenergetic levels, Kamila Jauch-Chara, M.D., from the University of Luebeck in Germany, and colleagues intranasally administered insulin (40 IU) or a placebo (within subject comparison) to 15 young (22 to 28 years of age), healthy, normal-weight men after an overnight fast and then measured cerebral energy metabolism by . At 100 minutes after treatment, the men were allowed to eat freely from a test buffet.

The researchers found that intranasal insulin increased , as determined by increased adenosine triphosphate and phosphocreatine levels, which was associated with a reduction in subsequent free-choice . The authors note that, consistent with this, their previous study showed that higher cerebral energy content was associated with lower .

"Brain energy levels may therefore constitute a predictive value for food intake," Jauch-Chara and colleagues conclude. "Given that the brain synchronizes food intake behavior in dependence of its current energetic status, a future challenge in obesity treatment may be to therapeutically influence cerebral energy homeostasis."

Explore further: Study evaluates intranasal insulin therapy for adults with mild cognitive impairment or Alzheimer's

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Study evaluates intranasal insulin therapy for adults with mild cognitive impairment or Alzheimer's

September 12, 2011
Intranasal insulin therapy appears to provide some benefit for cognitive function in patients with amnestic mild cognitive impairment and Alzheimer disease, according to a report published Online First today by Archives of ...

The metabolic effects of antipsychotic drugs

July 12, 2011
Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic ...

Insulin may influence body weight gain in former smokers

May 9, 2012
It is probably safe to say that smokers refuse to give up their vice because they believe their waistlines will only get bigger. And while most researchers have long speculated that a metabolic link exists between butting ...

Improving obesity-induced insulin sensitivity

June 1, 2012
In recent years, a growing body of evidence has linked inflammation to the development of insulin resistance. In insulin resistance, the hormone insulin is less effective in promoting glucose uptake from the bloodstream into ...

Obesity is associated with altered brain function

February 9, 2012
In most western countries the annual increase in the prevalence and the severity of obesity is currently substantial. Although obesity typically results simply from excessive energy intake, it is currently unclear why some ...

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.